Zhou Y - Search Results

1

Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma.

Zhao G, Jiang R, Shi Y, Gao S, Wang D, Li Z, Zhou Y, Sun J, Wu W, Peng J, Kuang T, Rong Y, Yuan J, Zhu S, Jin G, Wang Y, Lou W. Zhao G, et al. Among authors: zhou y. Mol Oncol. 2024 Apr 1. doi: 10.1002/1878-0261.13643. Online ahead of print. Mol Oncol. 2024. PMID: 38561976 Free article.

2

Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T₄, N₂ disease, positive resection margin, and receiving adjuvant chemotherapy.

Wu L, Xu Y, Zhou Y, Zeng Z, Fan Y, Wang D, Wu W, Guo X, Lv M, Ouyang Y, Du S, Lou W. Wu L, et al. Among authors: zhou y. Front Oncol. 2023 Jul 18;13:1109068. doi: 10.3389/fonc.2023.1109068. eCollection 2023. Front Oncol. 2023. PMID: 37534251 Free PMC article.

3

Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms.

Jiao F, Cui J, Fu D, Li Q, Wu Z, Teng Z, Zhang H, Zhou J, Zhang Z, Chen X, Zhou Y, Li Y, Mou Y, Qin R, Sun Y, Jin G, Cheng Y, Wang J, Ren G, Yue J, Jin G, Xiao X, Wang L; Pancreatic Tumor Group, Society of Oncology, Chinese Medical Association. Jiao F, et al. Among authors: zhou y, zhou j. Chin Med J (Engl). 2023 Oct 20;136(20):2397-2411. doi: 10.1097/CM9.0000000000002848. Epub 2023 Sep 8. Chin Med J (Engl). 2023. PMID: 37690992 Free PMC article. No abstract available.

4

Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial.

Guo X, Lou W, Xu Y, Zhuang R, Yao L, Wu J, Fu D, Zhang J, Liu J, Rong Y, Jin D, Wu W, Xu X, Ji Y, Wu L, Lv M, Yao X, Liu X, Wang D, Kuang T, Liu L, Wang W, Liu T, Zhou Y. Guo X, et al. Among authors: zhou y. Oncol Lett. 2024 Feb 19;27(4):161. doi: 10.3892/ol.2024.14293. eCollection 2024 Apr. Oncol Lett. 2024. PMID: 38449794 Free PMC article.

5

Identification of Novel Tumor Pyroptosis-Related Antigens and Pyroptosis Subtypes for Developing mRNA Vaccines in Pancreatic Adenocarcinoma.

Lin Q, Liang L, Wang Q, Wang X, You Y, Rong Y, Zhou Y, Guo X. Lin Q, et al. Among authors: zhou y. Biomedicines. 2024 Mar 25;12(4):726. doi: 10.3390/biomedicines12040726. Biomedicines. 2024. PMID: 38672082 Free PMC article.

6

Case report: Pathological complete response to perioperative treatment of radiotherapy combined with angiogenesis inhibitor in a patient with pleomorphic liposarcoma.

Zhang C, Liu W, Wang B, Zhu N, Guo X, Wang Z, Zhuang R, You Y, Zhang Y, Tong H, Lu W, Zhou Y. Zhang C, et al. Among authors: zhou y. Front Oncol. 2023 Jan 27;13:925233. doi: 10.3389/fonc.2023.925233. eCollection 2023. Front Oncol. 2023. PMID: 36776302 Free PMC article.

7

Corrigendum: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene.

Zhang J, Tang Z, Guo X, Wang Y, Zhou Y, Cai W. Zhang J, et al. Among authors: zhou y. Front Oncol. 2023 Oct 30;13:1303608. doi: 10.3389/fonc.2023.1303608. eCollection 2023. Front Oncol. 2023. PMID: 38023118 Free PMC article.

8

Clinical and pathological observation of conversion therapy for malignant peritoneal mesothelioma: a case report and literature review.

Deng M, Zhang X, Xu C, Luo R, Chen L, Zhou Y, Hou Y. Deng M, et al. Among authors: zhou y. Pathol Oncol Res. 2024 Jan 8;29:1611577. doi: 10.3389/pore.2023.1611577. eCollection 2023. Pathol Oncol Res. 2024. PMID: 38273860 Free PMC article. Review.

9

Insight of a lipid metabolism prognostic model to identify immune landscape and potential target for retroperitoneal liposarcoma.

Wang Z, Tao P, Fan P, Wang J, Rong T, Hou Y, Zhou Y, Lu W, Hong L, Ma L, Zhang Y, Tong H. Wang Z, et al. Among authors: zhou y. Front Immunol. 2023 Jul 6;14:1209396. doi: 10.3389/fimmu.2023.1209396. eCollection 2023. Front Immunol. 2023. PMID: 37483592 Free PMC article.

10

Clinical and surgical effectiveness of the multi-disciplinary standardized management model in the treatment of retroperitoneal liposarcoma: Evidence-based clinical practice experience from Fudan Zhongshan.

Fan P, Tao P, Wang J, Wang Z, Hou Y, Zhou Y, Lu W, Ma L, Zhang Y, Tong H. Fan P, et al. Among authors: zhou y. Surgery. 2024 May;175(5):1368-1376. doi: 10.1016/j.surg.2024.01.012. Epub 2024 Feb 22. Surgery. 2024. PMID: 38395638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67,443 results

Search Page